A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC)
Year: 2018
Type: article
Source: Annals of Oncology
Institutions: University Hospitals Seidman Cancer Center, Case Western Reserve University, Indiana University School of Medicine, Thomas Jefferson University, Sidney Kimmel Cancer Center, Virginia Oncology Associates, Washington University in St. Louis, University Hospitals of Cleveland, Hoosier Cancer Research Network (United States)
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2898539271
